Featured Content
Breast Cancer Risk Prediction Models
Studies explore the features to assess in a risk model to predict probability of breast cancer in women with benign breast biopsy or African American ...
Metabolic Health, Weight in Relation to Breast Cancer Risk
In one of the first studies to evaluate the association between insulin and breast cancer, fasting insulin levels may be useful to individualize screening.
Early-Stage Breast Cancer in Black Women
Even with early diagnosis, there appears to be a disproportionate toll from breast cancer in black women.
Mutation Frequency in Known Breast Cancer Predisposition Genes
How frequent are mutations in known breast cancer predisposition genes in women with TNBC who were unselected for family history?
Trastuzumab +Adjuvant Chemo for HER2+ Breast Cancer
Trastuzumab plus paclitaxel following doxorubicin and cyclophosphamide improves survival in early-stage HER2+ breast cancer.Breast Cancer News
Breast Cancer Resources
More Breast Cancer Information
How to Communicate Metastatic Breast Cancer Pain
This fact sheet educates patients on how to properly describe the details of their metastatic breast cancer pain to their oncologist.
Molecular Profiling: Personalizing Breast Cancer Treatment
This patient information fact sheet reviews how doctors use molecular profiling to offer patients more targeted therapy options.
BRCA1 and BRCA2: Cancer Risk and Genetic Testing
This fact sheet provides information about the BRCA1 and BRCA2 genes and related genetic testing.
Can Antiperspirants/Deodorants Cause Breast Cancer?
This fact sheet discusses evidence behind if antiperspirants and deodorants may be linked to breast cancer.
Hormone Therapy in Breast Cancer
This fact sheet teaches patients how hormone therapy can help stop the growth of hormone-sensitive breast cancer tumors.
HALAVEN (eribulin mesylate) for Refractory Metastatic Breast Cancer
This slideshow reviews drug information for HALAVEN (eribulin mesylate), indicated for refractory metastatic breast cancer. Table of Contents Slide 3: Indication, Dosage, ...
XELODA®
This slideshow reviews drug information for XELODA® (capecitabine) for treatment of metastatic breast cancer.
Table of Contents
Slide 3: Indication, Dosage, and ...
A 55-year-old Woman with Breast Cancer and Shortness of Breath
Chief Complaint
J.W. is a 55-year-old woman recently admitted to the hospital for worsening shortness of breath (Slide 1).
Relevant Medical History
• ...
Breast Cancer 101: From Incidence to Treatment
Breast cancer is one of the most frequently diagnosed types of cancer in the United States. In 2013, an estimated ...
Heart Failure During Breast Cancer Management: A Case Study
Byline: Sandra Cuellar Puri, PharmD, BCOP
Chief Complaint
During a routine follow-up visit, WM, a 48-year-old female, complains of ongoing fatigue since ...
Sign Up for Free e-newsletters
Cancer Therapy Advisor Articles
- Thyroid Ultrasound, Fine-Needle Aspiration May Increase Risk of Thyroid Cancer
- Patients with Thyroid Cancer Exhibit High Distress Levels
- Farydak Approved for Treatment of Multiple Myeloma
- At Year 3, Survival Curve of Ipilimumab-Treated Advanced Melanoma Begins to Plateau
- Prophylactic Effect of Urea-Based Cream on Sorafenib-Associated Hand-Foot Skin Reactions
- Breast Cancer Risk Prediction Models
- Current and Emerging Therapies for Bone Metastatic Castration-Resistant Prostate Cancer
- Optimal Prostate Screening Programs Could Significantly Help Lower Mortality
- Farydak Approved for Treatment of Multiple Myeloma
- Patients with Thyroid Cancer Exhibit High Distress Levels
- Prostate Tumor Androgen Receptor Abnormality Not Associated with Taxane Resistance
- Bicalutamide Improves Survival in Advanced Nonmetastatic Hormone-Naïve Prostate Cancer
- 4Kscore Might Reduce Unnecessary Prostate Biopsies
- Crizotinib Provides Benefit for ALK-Rearranged NSCLC with Brain Metastases
- Elderly Patients with Primary CNS Lymphoma Benefit from High-Dose Methotrexate Therapy
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
| Bone Cancer | Regimens | Drugs |
| Brain Cancer | Regimens | Drugs |
| Breast Cancer | Regimens | Drugs |
| Endocrine Cancer | Regimens | Drugs |
| Gastrointestinal Cancer | Regimens | Drugs |
| Genitourinary Cancer | Regimens | Drugs |
| Gynecologic Cancer | Regimens | Drugs |
| Head and Neck Cancer | Regimens | Drugs |
| Hematologic Cancer | Regimens | Drugs |
| Lung Cancer | Regimens | Drugs |
| Other Cancers | Regimens | |
| Rare Cancers | Regimens | |
| Skin Cancer | Regimens | Drugs |